Crossmark Global Holdings Inc. Sells 1,524 Shares of The Clorox Company (NYSE:CLX)

Crossmark Global Holdings Inc. lessened its position in The Clorox Company (NYSE:CLX) by 25.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,583 shares of the company’s stock after selling 1,524 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Clorox were worth $744,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CLX. Brooklyn Investment Group boosted its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new position in Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC grew its position in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP increased its stake in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox during the third quarter worth $48,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

Shares of CLX opened at $159.12 on Friday. The company has a 50 day moving average of $163.66 and a two-hundred day moving average of $157.32. The company has a market cap of $19.70 billion, a price-to-earnings ratio of 55.44, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the firm earned $0.49 EPS. The business’s quarterly revenue was up 27.0% on a year-over-year basis. As a group, analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. DA Davidson raised their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. boosted their price target on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday, January 16th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.